Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Key Drivers
3.1.1. Growing R&D For Tackling Several Diseases
3.1.2. Technological Advancements
3.2. Key Restraints
3.2.1. Extensive Time-Consuming Process
3.2.2. Highly Regulated Market
3.2.3. Project Feasibility And Success Rate

4. Key Analytics
4.1. Impact Of Covid-19 On Drug Discovery Market
4.2. Key Market Trends
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Drug Discovery And Development Process
4.5.1. Drug Discovery And Development
4.5.2. Preclinical Research
4.5.3. Clinical Research
4.5.4. Regulatory Authority Review
4.5.5. Post Market Safety Monitoring
4.6. Regulatory Framework

5. Market By Drug Type
5.1. Small Molecule Drug
5.2. Biologic Drug

6. Market By Service
6.1. Chemical Services
6.2. Drug Metabolism And Pharmacokinetics Services
6.3. Biological Services
6.4. Other Pharmaceutical Services

7. Market By End-User
7.1. Pharmaceutical Companies
7.2. Contract Research Organizations
7.3. Research Institutes
7.4. Other End-Users

8. Market By Technology
8.1. High Throughput Screening
8.2. Spectroscopy
8.3. Combinatorial Chemistry
8.4. Biochips
8.5. Pharmacogenomics And Pharmacogenetics
8.6. Bioinformatics
8.7. Metabolomics
8.8. Nanotechnology
8.9. Other Technologies

9. Geographical Analysis
9.1. Asia-Pacific
9.1.1. Market Size & Estimates
9.1.2. Key Growth Enablers
9.1.3. Key Challenges
9.1.4. Key Players
9.1.5. Country Analysis
9.1.5.1. China
9.1.5.2. Japan
9.1.5.3. India
9.1.5.4. South Korea
9.1.5.5. Indonesia
9.1.5.6. Singapore
9.1.5.7. Taiwan
9.1.5.8. Australia & New Zealand
9.1.5.9. Rest Of Asia-Pacific

10. Competitive Landscape
10.1. Key Strategic Developments
10.1.1. Mergers & Acquisitions
10.1.2. Product Launches & Developments
10.1.3. Partnerships & Agreements
10.1.4. Business Expansions & Divestitures
10.2. Company Profiles
10.2.1. Agilent Technologies Inc
10.2.2. Astrazeneca Plc
10.2.3. Bayer Ag
10.2.4. Charles River Laboratories International Inc
10.2.5. Eli Lilly And Company
10.2.6. Evotec Se
10.2.7. Glaxosmithkline Plc
10.2.8. Icon Plc
10.2.9. Iqvia Holdings Inc
10.2.10. Johnson & Johnson
10.2.11. Merck & Co Inc
10.2.12. Novartis Ag
10.2.13. Pfizer Inc
10.2.14. Roche Ag



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Drug Discovery And Development Process
Figure 5: Asia-Pacific Drug Discovery Market, Growth Potential, By Drug Type, In 2021
Figure 6: Asia-Pacific Drug Discovery Market, By Small Molecule Drug, 2022-2030 (In $ Million)
Figure 7: Asia-Pacific Drug Discovery Market, By Biologic Drug, 2022-2030 (In $ Million)
Figure 8: Asia-Pacific Drug Discovery Market, Growth Potential, By Service, In 2021
Figure 9: Asia-Pacific Drug Discovery Market, By Chemical Services, 2022-2030 (In $ Million)
Figure 10: Asia-Pacific Drug Discovery Market, By Drug Metabolism And Pharmacokinetics Services, 2022-2030 (In $ Million)
Figure 11: Asia-Pacific Drug Discovery Market, By Biological Services, 2022-2030 (In $ Million)
Figure 12: Asia-Pacific Drug Discovery Market, By Other Pharmaceutical Services, 2022-2030 (In $ Million)
Figure 13: Asia-Pacific Drug Discovery Market, Growth Potential, By End-User, In 2021
Figure 14: Asia-Pacific Drug Discovery Market, By Pharmaceutical Companies, 2022-2030 (In $ Million)
Figure 15: Asia-Pacific Drug Discovery Market, By Contract Research Organizations, 2022-2030 (In $ Million)
Figure 16: Asia-Pacific Drug Discovery Market, By Research Institutes, 2022-2030 (In $ Million)
Figure 17: Asia-Pacific Drug Discovery Market, By Other End-Users, 2022-2030 (In $ Million)
Figure 18: Asia-Pacific Drug Discovery Market, Growth Potential, By Technology, In 2021
Figure 19: Asia-Pacific Drug Discovery Market, By High Throughput Screening, 2022-2030 (In $ Million)
Figure 20: Asia-Pacific Drug Discovery Market, By Spectroscopy, 2022-2030 (In $ Million)
Figure 21: Asia-Pacific Drug Discovery Market, By Combinatorial Chemistry, 2022-2030 (In $ Million)
Figure 22: Asia-Pacific Drug Discovery Market, By Biochips, 2022-2030 (In $ Million)
Figure 23: Asia-Pacific Drug Discovery Market, By Pharmacogenomics And Pharmacogenetics, 2022-2030 (In $ Million)
Figure 24: Asia-Pacific Drug Discovery Market, By Bioinformatics, 2022-2030 (In $ Million)
Figure 25: Asia-Pacific Drug Discovery Market, By Metabolomics, 2022-2030 (In $ Million)
Figure 26: Asia-Pacific Drug Discovery Market, By Nanotechnology, 2022-2030 (In $ Million)
Figure 27: Asia-Pacific Drug Discovery Market, By Other Technologies, 2022-2030 (In $ Million)
Figure 28: Asia-Pacific-Pacific Drug Discovery Market, Country Outlook, 2021 & 2030 (In %)
Figure 29: China Drug Discovery Market, 2022-2030 (In $ Million)
Figure 30: Japan Drug Discovery Market, 2022-2030 (In $ Million)
Figure 31: India Drug Discovery Market, 2022-2030 (In $ Million)
Figure 32: South Korea Drug Discovery Market, 2022-2030 (In $ Million)
Figure 33: Indonesia Drug Discovery Market, 2022-2030 (In $ Million)
Figure 34: Singapore Drug Discovery Market, 2022-2030 (In $ Million)
Figure 35: Taiwan Drug Discovery Market, 2022-2030 (In $ Million)
Figure 36: Australia & New Zealand Drug Discovery Market, 2022-2030 (In $ Million)
Figure 37: Rest Of Asia-Pacific-Pacific Drug Discovery Market, 2022-2030 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - ASIA DRUG DISCOVERY
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: ASIA-PACIFIC DRUG DISCOVERY MARKET, BY DRUG TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC DRUG DISCOVERY MARKET, BY DRUG TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC DRUG DISCOVERY MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC DRUG DISCOVERY MARKET, BY SERVICE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC DRUG DISCOVERY MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC DRUG DISCOVERY MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC DRUG DISCOVERY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC DRUG DISCOVERY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC-PACIFIC DRUG DISCOVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC-PACIFIC DRUG DISCOVERY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 13: LEADING PLAYERS OPERATING IN ASIA-PACIFIC-PACIFIC DRUG DISCOVERY MARKET
TABLE 14: LIST OF MERGERS & ACQUISITIONS
TABLE 15: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 16: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 17: LIST OF BUSINESS EXPANSIONS & DIVESTITURES